A subchorionic hematoma is a collection of blood that forms between the chorion and the amnion, two of the fetal membranes that surround the fetus. It is a common complication of pregnancy, and it can occur in up to 10% of all pregnancies. While the majority of these hematomas resolve by themselves, some can become large and can cause complications. It is important for obstetricians to be aware of the potential risks and to chart the course of the hematoma size in order to determine the best course of action for the patient.
A subchorionic hematoma is a collection of blood that forms between the chorion and the amnion, two of the fetal membranes that surround the fetus. It is also known as a subchorionic hemorrhage, subchorionic bleed, or subchorionic collection. It is a common complication of pregnancy, and it can occur in up to 10% of all pregnancies. The hematoma is usually caused by a tear in the placenta, which is the organ that provides the fetus with oxygen and nutrients. The tear can be caused by trauma, such as a car accident, or it can occur spontaneously. The hematoma can range in size from a few millimeters to several centimeters.
Subchorionic hematomas are usually diagnosed during an ultrasound. The ultrasound will show a collection of fluid between the chorion and the amnion. The size of the hematoma will be measured and monitored over time to determine if it is getting larger or smaller. If the hematoma is small and is not causing any symptoms, it can usually be monitored without any intervention. The patient should be advised to rest and avoid any activities that could increase the risk of trauma to the uterus. If the hematoma is large, the patient may be placed on bed rest and medications may be prescribed to reduce the risk of preterm labor. If the hematoma is very large, the patient may be referred to a maternal-fetal medicine specialist for further evaluation and management.
Subchorionic hematomas can cause complications, such as preterm labor, placental abruption, and fetal growth restriction. The risk of these complications increases with the size of the hematoma. The risk of preterm labor is increased if the hematoma is larger than 20 millimeters. Placental abruption is a serious condition in which the placenta separates from the uterus, and it is more likely to occur if the hematoma is larger than 30 millimeters. Fetal growth restriction is a condition in which the fetus does not grow at the expected rate, and it is more likely to occur if the hematoma is larger than 40 millimeters.
It is important for obstetricians to chart the course of the hematoma size in order to determine the best course of action for the patient. The size of the hematoma should be measured at each ultrasound, and the measurements should be compared to the previous measurements. The rate of growth should also be monitored, as this can help to determine if the hematoma is increasing in size or not. If the hematoma is increasing in size, the patient should be closely monitored and any interventions should be considered. If the hematoma is decreasing in size, the patient should be monitored for any signs of complications and the patient should be advised to rest and avoid any activities that could increase the risk of trauma to the uterus.
Subchorionic hematomas are a common complication of pregnancy, and they can cause serious complications if they become large. It is important for obstetricians to be aware of the potential risks and to chart the course of the hematoma size in order to determine the best course of action for the patient. If the hematoma is increasing in size, the patient should be closely monitored and any interventions should be considered. If the hematoma is decreasing in size, the patient should be monitored for any signs of complications and the patient should be advised to rest and avoid any activities that could increase the risk of trauma to the uterus.
1.
Targeted radiation therapy shows near-complete response in rare sarcoma patients
2.
Researchers find distinct cell receptors with the potential for new treatments.
3.
It Is Not Just the Royals Who Go Through Cancer.
4.
Researchers Challenge USPSTF's Lung Cancer Screening Criteria
5.
Prostate cancer screening program beneficial in top decile of polygenic risk score
1.
AI in the War on Cancer: How Digital Tools are Revolutionizing Oncology
2.
Optimizing Chemotherapy Dosing: From Phase 1 Dose Escalation to Modification
3.
Everything You Need to Know About CA 19-9 and Cancer Diagnosis
4.
Unraveling the Mysteries of Lymphoma: A Journey into the Unknown
5.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
Navigating the Complexities of Ph Negative ALL - Part I
3.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
5.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation